Machine learning is improving the accuracy of molecular subtyping of breast cancer, which is crucial for selecting the most effective targeted therapies. Algorithms analyze genetic and molecular data to classify tumors into specific subtypes, aiding in the selection of treatment plans that are more likely to succeed.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.